Vinati Organics Ltd

AI

Vinati Organics Ltd

₹ 1,294 -1.38%
11 Sep 4:08 p.m.
About

Vinati Organics Ltd is an integrated
B2B manufacturer of the specialty
monomers, aromatics, butyl phenols, antioxidants, polymers and inorganic
/specialty intermediates, with four
manufacturing sites in Maharashtra
and exports to global chemical
customers.[1]

Key Points

Product Offerings:[1]
The company’s product portfolio
includes over 30 products across:
a) Specialty Aromatics:[2]
It offers Iso butyl benzene (IBB), N-Butyl
Benzene, Secondary Butyl Benzene (SBB),
Tertiary Amyl Benzene, and other intermediates
used to manufacture pharmaceutical products,
flavor and fragrance ingredients, polymer additives,
and more.
b) Specialty Monomers:[3]
It offers a range of chemicals like 2-acrylamido
2-methyl Propane Sulphonic Acid (ATBS), N-Tertiary Butyl Acrylamide, N-Tertiary Octyl Acrylamide, etc.
that are used for designing unique polymer structures.
c) Butyl Phenols:[4]
It manufactures Ortho Tertiary Butyl Phenol/2 Tert Butylphenol, Para Tertiary Butyl Phenol, 2, 6 Di Tert Butylphenol, etc.
d) Antioxidants:[5]
It offers Veenox 1010, Veenox 1076, Veenox 168, antioxidant blends, etc.
e) Miscellaneous Polymers:[6]
The company produces Miscellaneous Polymers like Vintreat Polymer, Vinplast 245, Vinflow HT, etc used in specialized applications such as construction, ceramics, etc.
f) Inorganic Chemicals:[7]
It also manufactures potassium bicarbonate used across industries, from food processing to healthcare.
g) New Products:
VOPL’s new chain includes anisole, MEHQ, guaiacol, BHA, 4-MAP, PTAP, 2,4-DTAP and tertiary-amyl alcohol.

  • Market Cap 13,444 Cr.
  • Current Price 1,294
  • High / Low 1,850 / 1,203
  • Stock P/E 30.0
  • Book Value 305
  • Dividend Yield 0.66 %
  • ROCE 19.8 %
  • ROE 14.9 %
  • Face Value 1.00

Pros

  • Company has reduced debt.
  • Company is almost debt free.
  • Company has been maintaining a healthy dividend payout of 20.5%

Cons

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
439 463 448 550 525 553 522 648 542 550 531 604 696
338 358 333 400 400 420 379 468 382 383 374 434 525
Operating Profit 100 105 115 150 124 134 142 180 160 167 157 170 170
OPM % 23% 23% 26% 27% 24% 24% 27% 28% 29% 30% 30% 28% 24%
10 11 9 10 9 22 7 6 7 16 9 20 9
Interest 1 1 1 1 0 0 0 0 0 0 0 0 0
Depreciation 17 17 19 20 21 22 22 23 26 26 29 30 32
Profit before tax 92 97 103 139 112 134 127 164 141 157 136 160 148
Tax % 25% 25% 25% 25% 25% 22% 26% 25% 26% 27% 26% 23% 26%
69 72 77 104 84 104 94 123 104 115 101 124 109
EPS in Rs 6.75 7.05 7.49 10.05 8.12 10.07 9.04 11.87 10.05 11.08 9.73 11.95 10.50
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
1,029 954 1,616 2,066 1,900 2,248 2,227 2,381
614 601 1,180 1,493 1,429 1,666 1,572 1,716
Operating Profit 415 353 435 573 471 582 655 665
OPM % 40% 37% 27% 28% 25% 26% 29% 28%
45 26 61 52 39 44 53 54
Interest 2 1 2 3 5 2 1 0
Depreciation 33 43 45 59 73 89 111 118
Profit before tax 425 335 449 563 432 536 595 601
Tax % 21% 20% 23% 26% 25% 24% 25%
334 269 347 419 323 405 444 448
EPS in Rs 32.48 26.20 33.72 40.78 31.15 39.09 42.80 43.26
Dividend Payout % 17% 23% 19% 17% 22% 19% 20%
Compounded Sales Growth
10 Years: %
5 Years: 18%
3 Years: 3%
TTM: 5%
Compounded Profit Growth
10 Years: %
5 Years: 11%
3 Years: 2%
TTM: 5%
Stock Price CAGR
10 Years: 16%
5 Years: -8%
3 Years: -12%
1 Year: -24%
Return on Equity
10 Years: %
5 Years: 17%
3 Years: 15%
Last Year: 15%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 10 10 10 10 10 10 10
Reserves 1,269 1,533 1,818 2,203 2,451 2,783 3,151
0 2 18 35 5 63 0
163 188 243 335 374 423 417
Total Liabilities 1,443 1,734 2,090 2,584 2,840 3,279 3,579
751 757 873 1,159 1,489 1,724 2,122
CWIP 31 56 51 242 249 438 214
Investments 227 289 94 227 64 36 190
434 632 1,071 955 1,038 1,081 1,053
Total Assets 1,443 1,734 2,090 2,584 2,840 3,279 3,579

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
416 219 127 515 332 458 558
-197 -198 -255 -329 -348 -443 -414
-109 -3 -47 -62 -108 -16 -141
Net Cash Flow 109 18 -175 124 -125 0 3
Free Cash Flow 279 136 -47 200 -65 -39 288
CFO/OP 124% 79% 54% 113% 89% 95% 106%

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 72 106 104 82 102 96 85
Inventory Days 79 115 75 79 72 68 110
Days Payable 47 63 46 41 36 45 43
Cash Conversion Cycle 104 158 132 120 137 118 152
Working Capital Days 97 138 137 109 141 115 130
ROCE % 24% 27% 28% 19% 20% 20%

Insights

In beta
Mar 2016 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
ATBS Installed Capacity
TPA

Log in to view insights

Please log in to see hidden values.

Login
IBB Installed Capacity
TPA
ATBS Global Market Share
%
Butyl Phenols Installed Capacity
TPA
Antioxidants (AO) Capacity Utilization
%
Antioxidants (AO) Installed Capacity
TPA
ATBS Capacity Utilization
%
Butyl Phenols Capacity Utilization
%

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
74.06% 74.06% 74.29% 74.29% 74.29% 74.29% 74.29% 74.29% 74.29% 74.29% 74.29% 74.29%
4.64% 4.71% 4.93% 5.33% 5.48% 5.31% 3.83% 3.86% 3.77% 3.77% 3.72% 3.65%
8.18% 7.55% 7.30% 6.74% 7.27% 7.61% 9.21% 9.25% 9.55% 9.84% 9.91% 9.20%
13.12% 13.69% 13.46% 13.64% 12.96% 12.81% 12.68% 12.60% 12.39% 12.11% 12.10% 12.86%
No. of Shareholders 93,9891,07,0221,06,8941,00,36393,50889,44187,93385,96085,00581,87478,60283,430

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Concalls